E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/16/2021 in the Prospect News High Yield Daily.

New Issue: ICON sells $500 million five-year secured notes at par to yield 2 7/8%

By Paul A. Harris

Portland, Ore., June 16 – ICON plc priced a $500 million issue of five-year senior secured notes (Ba1/BB+) at par to yield 2 7/8% on Wednesday, according to market sources.

The yield printed at the tight end of yield talk in the 3% area. Initial guidance was in the low 3% area.

The deal was heard to have been multiple-times oversubscribed, a trader said.

Citigroup was the lead left bookrunner. Morgan Stanley was a joint bookrunner. Joint lead managers were HSBC, JPMorgan and Santander.

Earlier in the week the company downsized the notes offering from $2.015 billion, eliminating a proposed $1.515 billion tranche of seven-year secured notes and shifting the proceeds to a concurrent bank loan.

Proceeds from the debt offerings will be used to fund the acquisition of PRA Health Services Inc. and refinance ICON’s and PRA’s debt.

The company is a Dublin-based provider of outsourced drug and device development and commercialization services.

Issuer:Indigo Merger Sub, Inc. (PRA Health Sciences, Inc. after merger closes)
Amount:$500 million
Maturity:July 15, 2026
Securities:Senior secured notes
Left bookrunner:Citigroup
Joint bookrunner:Morgan Stanley
Joint lead managers:HSBC, JPMorgan and Santander
Coupon:2 7/8%
Price:Par
Yield:2 7/8%
Spread:210 bps
First call:July 15, 2023 at 101.438
Trade date:June 16
Settlement date:July 1
Ratings:Moody's: Ba1
S&P: BB+
Distribution:Rule 144A and Regulation S for life
Price talk:3% area
Marketing:Roadshow

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.